ROCCUZZO, GABRIELE
 Distribuzione geografica
Continente #
NA - Nord America 505
EU - Europa 243
AS - Asia 168
AF - Africa 12
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 932
Nazione #
US - Stati Uniti d'America 502
IT - Italia 144
SG - Singapore 135
IE - Irlanda 35
SE - Svezia 21
CN - Cina 14
NG - Nigeria 12
FI - Finlandia 9
IN - India 7
CZ - Repubblica Ceca 6
DE - Germania 6
FR - Francia 5
TW - Taiwan 5
UA - Ucraina 4
CA - Canada 3
CH - Svizzera 3
ID - Indonesia 3
BE - Belgio 2
BR - Brasile 2
ES - Italia 2
HK - Hong Kong 2
JP - Giappone 2
NL - Olanda 2
PL - Polonia 2
AU - Australia 1
EU - Europa 1
HR - Croazia 1
MK - Macedonia 1
Totale 932
Città #
Singapore 116
Chandler 94
Santa Clara 63
Columbus 35
Dublin 35
Turin 30
Rome 24
Ashburn 22
Nyköping 19
Milan 18
Abuja 12
Medford 11
Princeton 11
Guangzhou 9
New York 6
Prague 6
Ann Arbor 5
Lappeenranta 5
Munich 5
Boston 4
Helsinki 4
Lausanne 3
Novara 3
Paris 3
Pune 3
Seattle 3
Sommariva Perno 3
Toronto 3
Andover 2
Antioch 2
Barcelona 2
Bari 2
Brussels 2
Foiano della Chiana 2
Gdansk 2
Hebei 2
Jakarta 2
Mogliano Veneto 2
Naples 2
Padova 2
Torgiano 2
Washington 2
West Jordan 2
Atlanta 1
Baricella 1
Beijing 1
Bengaluru 1
Boardman 1
Cape Coral 1
Casagiove 1
Cheyenne 1
Eitensheim 1
Genova 1
Grugliasco 1
Haimen 1
Hsinchu 1
Huskvarna 1
Jenera 1
Los Angeles 1
Marcianise 1
Mountain View 1
Nijmegen 1
Noida 1
Norwalk 1
Osasco 1
Palermo 1
San Giovanni Lupatoto 1
San Jose 1
Tokyo 1
Torino 1
Upper Marlboro 1
Woodbridge 1
Totale 614
Nome #
Folliculotropic Mycosis Fungoides: Current Guidance and Experience from Clinical Practice 59
Clinical significance of distant metastasis-free survival (Dmfs) in melanoma: A narrative review from adjuvant clinical trials 59
Association between Primary Cutaneous B-cell Lymphomas and Other Skin Cancers: A Multicentre Cohort Study 54
Extensive "halo naevi" phenomenon and regression of melanin during nivolumab treatment in metastatic melanoma: A predictor of a better outcome? 51
Guttate psoriasis in a patient with mycosis fungoides in treatment with Brentuximab vedotin: An unreported association 43
Patients with psoriasis resistant to multiple biological therapies: characteristics and definition of a difficult-to-treat population 43
Cutaneous B-cell lymphomas: Update on diagnosis, risk-stratification, and management 42
Sézary Syndrome: Different Erythroderma Morphological Features with Proposal for a Clinical Score System 41
Immune Check Point Inhibitors in Primary Cutaneous T-Cell Lymphomas: Biologic Rationale, Clinical Results and Future Perspectives 40
Real-life comparison between secukinumab and ixekizumab in the treatment of pustular and erythrodermic psoriasis 36
Current Controversies and Challenges on BRAF V600K-Mutant Cutaneous Melanoma 36
Clinical outcomes and management of JAK inhibitor-associated acne (JAKne) in patients with moderate-to-severe atopic dermatitis undergoing upadacitinib: A multicenter retrospective study 32
SARS-CoV-2 vaccine-related cutaneous manifestations: a systematic review 31
Regression of human papillomavirus-associated high-grade vaginal intraepithelial neoplasia after switching from ustekinumab to risankizumab in a psoriasis patient 29
Drug survival and efficacy of anti-interleukin 23 biologics in psoriasis: a comparative study on different agents 23
Obesity and immune-checkpoint inhibitors in advanced melanoma: A meta-analysis of survival outcomes from clinical studies 20
Synchronous occurrence of primary cutaneous B-cell lymphoma and cutaneous Rosai-Dorfman disease in distinct lesions: A unique association 19
Ocular Surface Disease in Patients With Atopic Dermatitis Treated With Dupilumab: A Prospective Case-Control Study 19
Emerging prognostic biomarkers in advanced cutaneous melanoma: a literature update 17
Interleukin-17 vs. Interleukin-23 Inhibitors in Pustular and Erythrodermic Psoriasis: A Retrospective, Multicentre Cohort Study 17
Identifying unmet needs and challenges in the definition of a plaque in mycosis fungoides: An EORTC-CLTG/ISCL survey 16
BRCA1-associated protein 1 c.368delG mutation leads to the development of multiple BAPomas and cutaneous melanomas: A novel pathogenic variant in BRCA1-associated protein tumor predisposition syndrome 16
Time to next treatment and safety assessment in cutaneous-T-cell lymphomas: a retrospective analysis on patients treated with bexarotene and acitretin 16
Retinoid-associated myopia in dermatologic patients: a systematic review 15
Visual symptoms in a patient treated with MEK inhibitors 15
Predictors of recurrence and progression in poorly differentiated cutaneous squamous cell carcinomas: insights from a real-life experience 13
Association between maternal dupilumab exposure and pregnancy outcomes in patients with moderate‐to‐severe atopic dermatitis: A nationwide retrospective cohort study 13
Impact of comorbidities in the response of atopic patients treated with dupilumab: a real-life study up to 36 weeks 13
Drug Survival of Anti Interleukin-17 and Interleukin -23 Agents after Adalimumab Failure in Hidradenitis Suppurativa: A Pilot Study 13
Phenotypic and Dermoscopic Patterns of Familial Melanocytic Lesions: A Pilot Study in a Third-Level Center 12
Real-world data on primary cutaneous lymphoproliferative disorders following SARS-CoV-2 vaccination: A multicentre experience from tertiary referral hospitals 12
Exploring Psoriasis Inflammatory Microenvironment by NanoString Technologies 12
Mixed purpuric and maculopapular eruption in a 70-year-old woman 11
Switching from adalimumab originator to biosimilars in hidradenitis suppurativa: What's beyond cost-effectiveness? 11
Clinical effectiveness of IL-17 and IL-23 inhibitors on difficult-to-treat psoriasis areas (scalp, genital, and palmoplantar sites): a retrospective, observational, single-center, real-life study 10
Real-Life Outcomes of Adjuvant Targeted Therapy and Anti-PD1 Agents in Stage III/IV Resected Melanoma 9
Concomitant cutaneous graft-versus-host disease and solid organ rejection: an unreported presentation 8
Advances in the pharmacological management of cutaneous T-cell lymphoma 8
Cutaneous adverse reactions following SARS‐CoV‐2 vaccine booster dose: a real‐life multicentre experience 8
Unveiling cutaneous adverse events and prognosis in immunotherapy for melanoma and squamous cell carcinoma 6
Maculopapular rash: An overlooked monkeypox diagnostic clue? 6
Psoriasis in Childbearing Age: A Real-Life, Retrospective, Single-Center Study on Anti-IL17 and IL-23 Agents 5
Topical ruxolitinib: A new treatment for vitiligo 5
Prognostic biomarkers in melanoma: a 2023 update from clinical trials in different therapeutic scenarios 4
Switching from IL23 inhibitors to IL17 inhibitors: A safe and effective practice? 4
Rechallenge and retreatment with topical imiquimod 5% in transplant recipients: A multicenter experience on actinic keratoses and basal cell carcinomas 4
Hand eczema: a review of clinical, dermoscopic and histological features 4
Anti‐IL17 Secukinumab in hidradenitis suppurativa: A long‐term drug survival analysis 3
Treatment Patterns and Outcomes of Stage III Melanoma Patients with Positive Sentinel Lymph Node Biopsy: A Real-Life Experience 3
New and emerging therapies in cutaneous T-cell lymphoma 3
Clinicopathological definition, management and prognostic value of mogamulizumab‐associated rash and other cutaneous events: A systematic review 3
Risankizumab-induced red face: a unique presentation 3
Predicting progression in very thin melanoma: the challenge of the next decade? 2
Pyoderma gangrenosum during infliximab in severe hidradenitis suppurativa: A paradoxical event 2
Dermoscopic predictors of melanoma in small diameter melanocytic lesions (mini‐melanoma): a retrospective multicentric study of 269 cases 2
Cutaneous T-cell Lymphoma Diagnostic and Therapeutic Trends amidst the COVID-19 Pandemic 2
Mogamulizumab associated crusted scabies: a rare diagnostic confounder 2
Análisis multicéntrico del manejo quirúrgico y tratamiento adyuvante de los pacientes con melanoma y positividad en la biopsia selectiva del ganglio centinela 2
‘Poroma-like’ branched vessels with rounded endings in dermoscopy of basal cell carcinoma: a new unusual structure 1
Rapidly evolving nasal ulceration: a clinical challenge 1
Collaborative efforts in studying Mediterranean melanoma families: A step towards precision medicine 1
Cutaneous T-cell lymphoma care across Europe: insights from the HORIZON programme 1
Clinical and Histopathological Findings in Palmoplantar Lichen Planus Presenting as Diffuse Keratoderma 1
Re: Regarding the Predictors of Recurrence and Progression in Poorly Differentiated Cutaneous Squamous Cell Carcinomas 1
Pyogenic-granuloma-like skin metastasis as first sign of hepatocarcinoma 1
Eosinophilic Dermatosis of Hematologic Malignancy: Emerging Evidence for the Role of Insect Bites—A Retrospective Clinico-Pathological Study of 35 Cases 1
Drug survival of biologics in hidradenitis suppurativa: A systematic review and meta-analysis 1
Immunotherapy in cutaneous melanoma and biologics in psoriatic disease: similarities and differences from a clinical multidisciplinary perspective 1
Totale 1.017
Categoria #
all - tutte 6.776
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.776


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202273 0 0 0 1 2 0 6 2 1 5 13 43
2022/2023309 20 33 4 20 23 39 14 72 29 5 31 19
2023/2024261 19 42 20 12 9 44 11 12 6 22 22 42
2024/2025374 6 78 24 73 193 0 0 0 0 0 0 0
Totale 1.017